Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

This randomized, double-blinded, placebo-controlled trial examined genetic influences on treatment response to sustained-release bupropion for smoking cessation. Smokers of European ancestry (N=291), who were randomized to receive bupropion or placebo (12 weeks) plus counseling, were genotyped for t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: David, Sean P., Brown, Richard A., Papandonatos, George D., Kahler, Christopher W., Lloyd-Richardson, Elizabeth E., Munafò, Marcus R., Shields, Peter G., Lerman, Caryn, Strong, David, McCaffery, Jeanne, Niaura, Raymond
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2007
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2039873/
https://ncbi.nlm.nih.gov/pubmed/17654295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14622200701382033
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller